On what fundamental basis does the stock justify a price of $2.50, Floydf?
The business's operations (operating and investing cash flows) have generated negative $22m over the last 4 years, so the reality is that the business is not yet self-funding and is insteat fund its dividend out of financing activies (e.g. raising equity). ROE has fallen from roughly 20% to roughly 12%, and at the price they've paid for DMX, the ROE will not improve. As i've said before, they've invested about $93m in the business over the last 3 years (before you even take into account the DMX acquisition), and haven't generated an appropriate return from that capital.
A price of $2.50 would require an enormous improvement in their capital efficiency. There are growth stocks out there with 15%+ ROEs, 5%+ fully franked dividends who can fund their capital requirements from operating cash flow - TOX is not even relative value let alone absolute value in my opinion.
The short-term SP movements don't mean anything - it's quite possible that the underwriters to the recent institutional placement have provided after-market price support to the stock to maximise the SPP take-up by retail punters. The real test for the share price will be what happens post the SPP.
- Forums
- ASX - By Stock
- to invest in the spp, or not?
On what fundamental basis does the stock justify a price of...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TOX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online